?
CD44 Isoform Composition Is Associated with the Progression Rate of Left-Sided Colorectal Cancer of the CMS4 Subtype
The hyaluronic acid receptor CD44 is involved in colorectal cancer (CRC) progression, yet data
on its association with tumor progression rate are contradictory. Using TCGA data (n = 379), we assessed
total CD44, isoforms 2, 3, 4 and the isoform 3: isoform 4 ratio for overall (OS) and progression-free (PFS)
survival analysis across the whole cohort, CMS subtypes and tumor side. It was identified that total CD44
was not associated with tumor progression rate. Isoform composition, on the other hand, mainly the isoform
3:4 ratio, was informative. Significance was concentrated in left-sided CRC, mainly the CMS4 subtype: a
high 3:4 ratio and high isoform 3 were favorable and high isoform 4 unfavorable (OS and PFS), linking CD44
isoform composition to the tumor progression rate. We conclude that the prognostic value of CD44 is determined
not by total expression but by isoform composition and context (side, subtype).